Myelomas
A phase II trial of daratumumab, lenalidomide and dexamethasone (DRd) in combination with selinexor for patients with newly diagnosed multiple myeloma (USOR 20285)
- Details
ClinicalTrials.gov ID:
NCT04782687
Diagnosis Type:
NA
USOR Number:
- Address
520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001